Skip to content

Author

Xin Yin

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

OX40 ligand-engineered dendritic cell nanovesicles potentiate antitumor immunity through dual-mode T cell activation.

A ClyA-mediated membrane functionalization strategy provides a versatile tool for engineering cell-derived vesicles, and OX40L-engineered DC nanovesicles offer a promising platform for developing next-generation personalized cancer vaccines.

Zhong-Qian Yang, Yi-Ting Ding, Ying Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.